PDPR2P: A Potential Drug Target and Biomarker (G283922)

Target Name: PDPR2P

NCBI ID: G283922

PDPR2P

Other Name(s): pyruvate dehydrogenase phosphatase regulatory subunit 2, pseudogene | Pyruvate dehydrogenase phosphatase regulatory subunit 2, pseudogene

PDPR2P: A Potential Drug Target and Biomarker

PDPR2P, also known as pyruvate dehydrogenase phosphatase regulatory subunit 2, is a protein that is expressed in various tissues and cells throughout the body. It is a key enzyme in the pyruvate pathway, which is a critical metabolic pathway that is involved in the production of energy from the food we eat.

PDPR2P is a regulatory subunit, which means that it is a component of a larger protein that functions as a team. In this case, the protein is called PDPR2P-PDase, which is a complex that includes two subunits: PDPR2P and PDPR2P-CTN. The PDPR2P subunit is responsible for catalyzing the conversion of pyruvate to lactate, while the PDPR2P-CTN subunit is responsible for regulating the activity of PDPR2P.

PDPR2P is also a pseudogene, which means that it is a genetic segment of DNA that has the potential to produce a functional protein. In fact,PDPR2P is one of the most well-studied pseudogenes, and several studies have identified its potential as a drug target or biomarker.

One of the reasons why PDPR2P is considered a drug target is its involvement in the production of cancer.PDPR2P has been shown to play a role in the development and progression of several types of cancer, including breast, ovarian, and colorectal cancer.

In addition to its potential as a cancer drug target, PDPR2P is also a biomarker for several diseases, including cancer, diabetes, and neurodegenerative disorders.

PDPR2P has also been shown to be involved in the regulation of cellular processes that are important for brain function, such as cell signaling and neurotransmitter production. This suggests that it may be a potential target for drugs that are designed to improve brain health or treat neurological disorders.

Another potential use for PDPR2P as a drug target is its role in the regulation of cellular processes that are important for the immune system.PDPR2P has been shown to play a role in the production of immune cells, which is important for protecting the body against infection and disease.

In addition to its potential as a drug target or biomarker, PDPR2P is also of interest to researchers as a potential therapeutic target. Several studies have shown that inhibiting the activity of PDPR2P has the potential to treat several diseases, including cancer, diabetes, and neurological disorders.

In conclusion, PDPR2P is a protein that is expressed in various tissues and cells throughout the body and is involved in the production of energy from the food we eat.It is also a pseudogene and has been shown to play a role in the development and progression of cancer, as well as in the regulation of cellular processes that are important for brain function and immune system. PDPR2P may be a potential drug target or biomarker, and its potential therapeutic effects are being investigated.

Protein Name: Pyruvate Dehydrogenase Phosphatase Regulatory Subunit 2, Pseudogene

The "PDPR2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDPR2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets